Hospital or health organisation · founded 1981
Moffitt Cancer Center
Tampa, United States · moffitt.org
- Citations, last 5 years
- 134.7k
- Works, last 5 years
- 13.7k
- h-index
- 815
- Scientists listed
- 950
- Grants since 2016
- 1 073
Grants received
2019–2029 · training · T32
Behavioral Oncology Education & Career Development
Vani N Simmons · Moffitt Cancer Center · funded by National Institutes of Health
2019–2026 · research · R37
Developing and credentialing patient-derived xenograft models to advance therapeutic approaches for chronic myelomonocytic leukemia
Eric Padron · Moffitt Cancer Center · funded by National Institutes of Health
2019–2030 · research · R35
Illuminating Notch receptor-ligand selectivity through structure-guided protein engineering
Vincent Christopher Luca · Moffitt Cancer Center · funded by National Institutes of Health
2019–2026 · research · R37
Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology
Daniel Jeong · Moffitt Cancer Center · funded by National Institutes of Health
2018–2020 · research · R21
Autohistomagnetic Isolation of Tumor-reactive T-cells
Adam William Mailloux · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
B cell-dependent anti-tumor immunity in ovarian cancer
Jose R Conejo-Garcia · Moffitt Cancer Center · funded by National Institutes of Health
2018–2019 · research · R21
MALAT1 Depletion as a Therapeutic Strategy in Chronic Myelomonocytic Leukemia (CMML)
Eric Padron · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers
Thomas D Bannister · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
Eco-Evolutionary dynamics of NSCLC to immunotherapy: Response and Resistance
Alexander Robertson Allan Anderson · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Improving Prediction of Chemotherapy-Induced Nausea: Integrating Genes, Behavior, and the Microbiome
Heather S.L. Jim · Moffitt Cancer Center · funded by National Institutes of Health
2018–2019 · fellowship · F31
Determining the role of intratumoral dendritic cells in anti-tumor immunity
Alycia Gardner · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R37
Investigation of NRF2-Dependent Metabolic Liabilities
Gina Marie Denicola · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer
John L. Cleveland · Moffitt Cancer Center · funded by National Institutes of Health
2018–2020 · research · R03
An ESC-GEMM platform for rapid melanoma mouse modeling
Florian Karreth · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R37
Investigation of NRF2-Dependent Metabolic Liabilities
Gina Marie Denicola · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue
Heather S.L. Jim · Moffitt Cancer Center · funded by National Institutes of Health
2018 · fellowship · Rita Allen Foundation Scholar
Vincent Luca
Vincent Luca · Moffitt Cancer Center · funded by Rita Allen Foundation
2018–2023 · research · R01
Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers
Thomas D Bannister · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
PhI/II Study of CD8-Reduced T Cells for Treatment of MDS or AML IND17305 (12/30/2016)
Hany Elmariah · Moffitt Cancer Center · funded by U.S. Food and Drug Administration
2018–2023 · cooperative agreement · U01
Rapid Exoproteome Antigen Profiling of antibodies produced in the ovarian cancer microenvironment
Jose R Conejo-Garcia · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R37
Investigation of NRF2-Dependent Metabolic Liabilities
Gina Marie Denicola · Moffitt Cancer Center · funded by National Institutes of Health
2018–2021 · career development · K22
Investigating mechanistic underpinnings and therapeutic potential of selective histone deacetylase and bromodomain inhibition for the treatment of non-small cell lung cancer
Dennis O Adeegbe · Moffitt Cancer Center · funded by National Institutes of Health
2018–2021 · research · R21
Autohistomagnetic Isolation of Tumor-reactive T-cells
Adam William Mailloux · Moffitt Cancer Center · funded by National Institutes of Health
2018–2021 · research · R34
Development of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking Cessation
Christine Vinci · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R37
Investigation of NRF2-Dependent Metabolic Liabilities
Gina Marie Denicola · Moffitt Cancer Center · funded by National Institutes of Health
2018–2020 · award
CD277/Butyrophilin 3A1 is a targetable immune regulator in cancer.
Kyle Payne · Moffitt Cancer Center · funded by American Cancer Society
2018–2023 · research · R37
Investigation of NRF2-Dependent Metabolic Liabilities
Gina Marie Denicola · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · award
Prevention of Infection-Related Cancers
Anna Giuliano · Moffitt Cancer Center · funded by American Cancer Society
2018–2019 · contract · N01
PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES CELL MANUFACTURING AND PROCESS DEVELOPMENT SERVICES FOR PCT0005-02: CRYOPRESERVATION TECHNICAL STUDY
Linda Kelley · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue
Heather S.L. Jim · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer
John L. Cleveland · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer
John L. Cleveland · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers
Thomas D Bannister · Moffitt Cancer Center · funded by National Institutes of Health
2018–2019 · research · R13
The 9th International MDM2 Workshop
Jiandong Chen · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Improving Prediction of Chemotherapy-Induced Nausea: Integrating Genes, Behavior, and the Microbiome
Heather S.L. Jim · Moffitt Cancer Center · funded by National Institutes of Health
2018–2024 · research · R01
Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers
Thomas D Bannister · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
B cell-dependent anti-tumor immunity in ovarian cancer
Jose R Conejo-Garcia · Moffitt Cancer Center · funded by National Institutes of Health
2018–2021 · research · R34
Development of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking Cessation
Christine Vinci · Moffitt Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer
John L. Cleveland · Moffitt Cancer Center · funded by National Institutes of Health
2018–2019 · research · R21
MALAT1 Depletion as a Therapeutic Strategy in Chronic Myelomonocytic Leukemia (CMML)
Eric Padron · Moffitt Cancer Center · funded by National Institutes of Health